Supplemental material
Report
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
Abdullah Elsayeda Philochem AG, Libernstrasse 3, Otelfingen, Switzerland;b Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland
https://orcid.org/0000-0001-7080-0853View further author information
https://orcid.org/0000-0001-7080-0853View further author information, Christian Pellegrinoc Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerlandhttps://orcid.org/0000-0001-7898-9988View further author information
https://orcid.org/0000-0001-7898-9988View further author information, , , , , Gudrun Thorhallsdottira Philochem AG, Libernstrasse 3, Otelfingen, Switzerland;b Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerlandhttps://orcid.org/0009-0005-0604-7728View further author information
https://orcid.org/0009-0005-0604-7728View further author information, , , Jacqueline Mocka Philochem AG, Libernstrasse 3, Otelfingen, Switzerlandhttps://orcid.org/0000-0002-4618-1113View further author information
https://orcid.org/0000-0002-4618-1113View further author information, Emanuele Pucaa Philochem AG, Libernstrasse 3, Otelfingen, Switzerlandhttps://orcid.org/0000-0002-2869-3203View further author information
https://orcid.org/0000-0002-2869-3203View further author information, Roberto De Lucaa Philochem AG, Libernstrasse 3, Otelfingen, Switzerlandhttps://orcid.org/0000-0001-7519-8689View further author information
https://orcid.org/0000-0001-7519-8689View further author information, Markus G. Manzc Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerlandhttps://orcid.org/0000-0002-4676-7931View further author information
https://orcid.org/0000-0002-4676-7931View further author information, Cornelia Halinb Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerlandhttps://orcid.org/0000-0002-7899-2850View further author information
https://orcid.org/0000-0002-7899-2850View further author information & Dario Neria Philochem AG, Libernstrasse 3, Otelfingen, Switzerland;b Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland;d Philogen SpA, Siena (S), ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-5234-7370View further author information
https://orcid.org/0000-0001-5234-7370View further author information show all